Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell Line

Table 1

Association between miRNA-140 expression and clinicopathological features.

Variable		Low ()	High ()	^2
Biological sex
Female	11	6	5	0.105	0.745
Male	69	34	35
Age, years
<60	62	30	32	0.287	0.592
≥60	18	10	8
Drinking history
No	63	31	32	0.075	0.785
Yes	17	9	8
Family history
No	71	36	35	0.125	0.723
Yes	9	4	5
BMI
≤25	68	34	34	0.000	1.000
>25	12	6	6
AFP
<400	38	18	20	0.201	0.654
≥400	42	22	20
Liver cirrhosis
No	18	7	11	1.147	0.284
Yes	62	33	29
Number of tumor
<3	63	30	33	0.672	0.412
≥3	17	10	7
Metastasis
No	70	34	36	0.457	0.499
Yes	10	6	4
BCLC stage
0/A	51	21	30	4.381	0.036
B/C	29	19	10
PVTT
No	70	35	34	0.105	0.745
Yes	10	5	6

Abbreviations: BMI: body mass index; AFP: alpha-fetoprotein; PVTT: portal vein tumor thrombus; BCLC stage: Barcelona Clinic Liver Cancer stage.